PubMed ID:
35017169
Public Release Type:
Journal
Publication Year: 2022
Affiliation: Clinical Translational Research Accelerator, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington.; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.; Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.; Clinical Translational Research Accelerator, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.; Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington.; Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.; Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.; Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; Division of Nephrology and Hypertension, Vanderbilt University School of Medicine, Nashville, Tennessee.; Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania.; Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Division of Nephrology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.; Division of Nephrology, Department of Medicine, University of Texas Joe and Teresa Long School of Medicine, San Antonio, Texas.; Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Division of Kidney, Urologic, and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.; Division of Nephrology, Veterans Affairs New York Harbor Healthcare System and New York University School of Medicine, New York, New York.; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington.; Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington.; Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.; Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
DOI:
https://doi.org/10.1681/ASN.2021060757
Authors:
Mansour Sherry G, Bhatraju Pavan K, Coca Steven G, Obeid Wassim, Wilson Francis P, Stanaway Ian B, Jia Yaqi, Thiessen-Philbrook Heather, Go Alan S, Ikizler T Alp, Siew Edward D, Chinchilli Vernon M, Hsu Chi-Yuan, Garg Amit X, Reeves W Brian, Liu Kathleen D, Kimmel Paul L, Kaufman James S, Wurfel Mark M, Himmelfarb Jonathan, Parikh Samir M, Parikh Chirag R
Request IDs:
20898
,
21327
,
21469
,
21974
,
22361
,
22676
Studies:
Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury
The mechanisms underlying long-term sequelae after AKI remain unclear. Vessel instability, an early response to endothelial injury, may reflect a shared mechanism and early trigger for CKD and heart failure.